Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
- 1 September 2005
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 344 (1) , 147-149
- https://doi.org/10.1016/j.ab.2005.04.038
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Novel Diagnostic Test for Acute StrokeStroke, 2004
- Effect of Anticoagulants and Cell Separation Media as Preanalytical Determinants on Zymographic Analysis of Plasma Matrix MetalloproteinasesClinical Chemistry, 2003
- Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasmaAnalytical Biochemistry, 2003
- Metalloproteinases 2 and 9 are increased in plasma of patients with heart failureEuropean Journal of Clinical Investigation, 2003
- Plasma MMP‐9 (92 kDa‐MMP) activity is useful in the follow‐up and in the assessment of prognosis in breast cancer patientsInternational Journal of Cancer, 2003
- Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular DiseaseCirculation, 2003
- Effects of Blood Collection Methods on Gelatin Zymography of Matrix MetalloproteinasesClinical Chemistry, 2003
- Matrix Metalloproteinases in Lung DiseasesCurrent Protein & Peptide Science, 2002
- Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patientsInternational Journal of Cancer, 2000
- Quantitative Zymography: Detection of Picogram Quantities of GelatinasesAnalytical Biochemistry, 1994